The global demand for Sepsis Diagnostics Market is presumed to reach the market size of nearly USD 1604.63 MN by 2028 from USD 721.9 MN in 2021 with a CAGR of 10.5% under the study period 2022 - 2028.
Sepsis diagnostics refers to the tests and procedures that are used to diagnose sepsis. Sepsis is a condition in which infection spreads in the whole body and triggers a widespread immune response. It can be difficult to diagnose as its symptoms can mimic those of other illnesses. The goal of sepsis diagnostics is to identify the presence of sepsis as quickly as possible so that appropriate treatment can be initiated. This can include blood tests to detect markers of infection, imaging tests to identify the source of the infection, and other diagnostic procedures to determine the severity of the condition and to guide treatment decisions.
Sepsis is a leading cause of death globally, and its incidence is increasing due to the ageing population, the rise of chronic diseases, and the increasing use of medical devices that can increase the risk of sepsis. The increase in public awareness of sepsis, driven by increased media coverage and advocacy efforts is driving demand for sepsis diagnostics. Advances in diagnostic technologies, such as molecular diagnostics, have improved the accuracy and speed of sepsis diagnosis, making it easier to identify and treat sepsis in its early stages. The growing healthcare expenditure in developed and developing countries is driving the growth of the sepsis diagnostics market as healthcare providers look to improve the quality of care for their patients. Increase in sepsis diagnostics, driven by the need to improve patient recovery and reduce the cost of care is also pushing the market demand.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of sepsis diagnostics. The growth and trends of sepsis diagnostics industry provide a holistic approach to this study.
This section of the sepsis diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By Technology
By Pathogen
By Testing Type
By Method
By End-User
This section covers the regional outlook, which accentuates current and future demand for the Sepsis Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the sepsis diagnostics market include bioMérieux SA, Becton, Dickinson & Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Danaher Corp. (Beckman Coulter, Inc.), Luminex Corp., Bruker Corp., Amara Health Analytics, Wolters Kluwer N.V., Cerner Corp., Epic Systems Corporation, Mckesson Corp., GE Healthcare, Koninklijke Philips N.V. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Avail customized purchase options to meet your exact research needs: